Recent News
Feb 28, 2025
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress
Events and presentations
Apr 07, 2025
24th Annual Needham Virtual Healthcare Conference
Mar 27, 2025
H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference (Skin Diseases, Conditions and Disorders)
Our commitment to patients
At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve and extend patients’ lives.
read onMeet the Blue Crew
Meet the Blue Crew
Alexandra Cheng, Senior Director, Commercial Strategy
As the commercial lead on the mast cell program team, I develop long-range strategies to maximize the impact of our mast cell therapies on patients worldwide. I am focused on understanding the needs of the patients and healthcare providers that we serve, and ensuring that our strategy is grounded in those needs.
Read onWe aspire to advance the scientific understanding of disease and pioneer life-changing medicines for patients. To learn more about our scientific leadership and perspectives, visit Our Blueprint.
read on“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat serious diseases.”Kate Haviland, Chief Executive Officer
“We ignore traditional boundaries and let science drive us. It’s the only way to revolutionize how we treat serious diseases.”Kate Haviland, Chief Executive Officer
Dare to be different
We believe diversity is the key to unlocking our full potential. We push boundaries and take well-calculated risks, committing courageously and wholeheartedly to what we believe in.
read on